mutations and complex kar yotype. It follows a linear evolution within the CLL clone in the recurrent acquisition of CDKN2A Genetic susceptibility mechanisms. Most susceptibility loci map to non-coding locations on the genome, are largely situated in Lively promoters or enhancers, and modify the